Reach Us +44-1477412632


Psychopharmacology and Intellectual Disability: The Continuing Dilemmas of "Challenging Behaviour"

Optimal pharmacotherapy in treating the mental disorders seen in persons with intellectual disabilities relies on care plans formulated on a broad biopsychosocial perspective.

  • An inclination for these individuals to present with behavioral features, particularly aggression, has contributed to a long-standing pattern of overuse of antipsychotic medications.
  • Many jurisdictions, having closed their traditional institutions, have yet to establish the specialized secondary and tertiary mental health services needed to provide care and relevant professional training.
  • Contemporary advances in genetics and neuroscience hold promise in facilitating accurate diagnosis and individualized medical interventions i.e., “personalized medicine” for these individuals.


Bruce D McCrearyl

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs